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Abstract The evident ataxic characteristics of gait in patients with cerebellar damage suggest that
the cerebellum plays an important role in the neural control of gait. Ataxic features, such as increased
gait variability and increased step width, are often related to gait stability. However, the link between
these measures and gait stability is not straightforward. Therefore, to gain more insights into relations
between gait stability, gait variability and gait ataxia, we quantified gait stability using the short-term
maximum Lyapunov exponent. This is a more valid measure of gait stability, derived from dynamical
systems theory. Eighteen patients with focal cerebellar lesions after tumor resection walked on an
instrumented treadmill at 1.0 m/s for three minutes. The patients displayed relatively mild functional
deficits (ICARS = 6.9 ± 6.4, range 0 − 20) and had a lower overground walking speed as compared
to healthy controls (1.12 m/s versus 1.31 m/s). During treadmill walking, the short-term maximum
Lyapunov exponent was higher in cerebellar patients, indicating reduced gait stability. Furthermore,
step width was increased in the patient group while other spatio-temporal gait parameters were similar.
Patients with the largest lesions in the vermis displayed the least stable gait pattern. These observations
imply that the short-term maximum Lyapunov exponent is a sensitive measure of gait deficits in mildly
ataxic cerebellar patients.
Highlights Gait stability was quantified using the short-term maximum Lyapunov exponent; Gait
stability was reduced in mildly ataxic patients with focal cerebellar lesions; Vermal lesion size correlated
with gait stability (Lyapunov exponent); Step width was increased in the patients and was correlated
to ataxia severity
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1 Introduction
The evident ataxic characteristics of gait in patients
with cerebellar damage suggest that the cerebellum
plays an important role in the neural control of gait
[for review: 1]. Prominent ataxic gait features in-
clude increased gait variability [2, 3, 4, 5, 6, 7, 8,
9, 10] and an increased step width [2, 3, 5, 8, 9].
Increased gait variability is often used to infer re-
duced gait stability [for review: 11] and, similarly,
step width has been used as a measure of gait stabil-
ity, for instance in cerebellar lesion patients [3]. In
this group increased step length variability has been
associated with damage in specific areas in the cere-
bellum, partially different from cerebellar areas re-
lated to increased lateral sway and step width [3, 4].
These observations are important since the individ-
ual contributions of balance and limb-coordination
deficits to ataxic gait are still under debate [2, 12].
Furthermore, increased gait variability, specifically
during slow walking, has been linked to fall risk in
cerebellar ataxia patients [7].
However, the link between gait variability and
gait stability is not straightforward. From a
biomechanical perspective, increased variability it-
self does not necessarily imply decreased stability,
since stability depends on both the constraints and
the control strategy of a system (for discussion, see
[11]). This notion is important since in cerebellar
patients increased gait variability could be related
to cerebellar deficits in intra-limb coordination [2],
rather than to gait stability.
Likewise, step width is also not an ideal measure
to quantify gait stability. In order not to fall, the
center of mass needs to be controlled such that it
stays over the base of support. For dynamic condi-
tions, such as gait, this is best assessed using the ex-
trapolated center of mass concept [13]. The extrap-
olated center of mass combines center of mass posi-
tion and velocity, and it should be within the base
of support [11, 13]. Because the distance between
the extrapolated center of mass and the boundary
of the base of support (the ‘margin of stability’), is
not only affected by step width but also by move-
ments of the rest of the body, it is clear that an in-
creased step width does not necessarily imply more
stability.
A more valid [11] measure for gait stability is the
short-term maximum Lyapunov exponent [14], de-
rived from dynamical systems theory. This measure
quantifies the ability to recover from small pertur-
bations. It has a valid theoretical basis and has
been shown to have a high predictive validity with
respect to falling in both modeling and observa-
tional studies [for review: 11]. While this measure
has been used to evaluate gait stability in many dif-
ferent populations such as elderly [15, 16], amputees
[17, 18] and patients with knee osteoarthritis [19],
anterior cruciate ligament deficiency [20] and pe-
ripheral neuropathy [21], so far it has, to the best
of our knowledge, not been used to evaluate gait
stability in cerebellar ataxia patients.
Here, we aimed to gain more insight into rela-
tions between gait stability, gait variability and gait
ataxia. Therefore, we assessed gait stability and
variability in a group of patients with focal cere-
bellar lesions after tumor resection. We specifically
focused on stability in the medio-lateral direction
in these mildly ataxic cerebellar patients, inspired
by the commonly observed increased step width in
cerebellar ataxia. We quantified gait stability us-
ing the short-term maximum Lyapunov exponent
[11, 14] and we evaluated the margin of stability
based on the extrapolated center of mass [13]. We
hypothesized that patients would walk with a less
stable gait pattern and with a reduced margin of
stability. Specifically, we expected that the short-
term maximum Lyapunov exponent would make an
important contribution to the description of gait
deficits in this mildly ataxic patient group.
2 Materials and methods
2.1 Participants & Protocol
Eighteen cerebellar patients (age: 24.4 ± 7.3 yrs;
mean±SD; 13 female, 5 male) and fourteen healthy
participants (24.4± 3.5; 11 female, 3 male) partic-
ipated in the study. All patients displayed chronic
focal lesions after cerebellar tumor resection (var-
ious types, see Table 1). Nine patients received
radiation therapy and four of them chemotherapy
(Table 1). Lesion sizes are summarized in Table 1
(more details on lesion locations and on magnetic
resonance imaging data acquisition and analysis
procedures can be found in the supplementary ma-
terials). All patients were in a stable condition
(> 2 years post-op; range 4.8 − 30.2 yrs; Table 1).
Severity of ataxia was rated using the International
Cooperative Ataxia Rating Scale [ICARS; 22]. All
participants gave written informed consent, as ap-
proved by the local ethics committee and in accor-
dance with the Declaration of Helsinki.
Participants performed three trials of overground
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Table 1: All patients had stable focal lesions after cerebellar tumor resection
Vermal
Time Lesion Lesion ICARS Adjuvant
# Age Post-op Sex Diagnosis Volume Volume Total P&G Kin Fun Therapies
(years) (years) (cm3) (cm3) /100 /34 /52 Radiation Chemo
1 28.8 13.9 f Lhermitte Duclos Disease 58.0 - 3 1 1 - -
2 20.2 8.7 f Pilocytic Astrocytoma 8.2 - 3 0 0 - -
3 18.1 6.5 f Pilocytic Astrocytoma 4.5 - 1 0 1 - -
4 19.6 11.8 m Pilocytic Astrocytoma 1.7 1.1 6 3 2 - -
5 20.5 4.8 f Pilocytic Astrocytoma 47.3 5.6 3 1 1 - -
6 20.5 13.1 f Pilocytic Astrocytoma 36.3 - 2 1 0 - -
7 19.0 13.2 m Pilocytic Astrocytoma 15.7 - 7 2 5 - -
8 41.2 28.1 f Pilocytic Astrocytoma 20.2 4.9 20 6 10 Y -
9 26.9 24.9 f Pilocytic Astrocytoma 58.4 - 5 1 1 Y -
10 22.0 18.7 m Astrocytoma grade II 2.0 0.7 1 0 1 - -
11 21.6 19.5 f Astrocytoma grade II 7.1 2.1 0 0 0 Y -
12 31.4 19.7 f Astrocytoma grade III 8.6 0.4 11 5 4 Y -
13 22.3 17.7 m Medulloblastoma 22.0 3.3 13 6 2 Y -
14 18.6 13.6 m Medulloblastoma 6.3 2.5 19 5 10 Y Y
15 18.4 15.5 f Medulloblastoma 5.4 2.2 5 1 3 Y Y
16 31.3 18.2 f Medulloblastoma 14.2 4.0 17 10 4 Y Y
17 18.5 10.0 f Medulloblastoma 22.6 5.2 2 1 1 Y Y
18 39.9 30.2 f Hemangioblastoma no MRI no MRI 6 4 2 - -
For patient 18 no MRI data was acquired. ICARS = International Cooperative Ataxia Rating Scale [22]; P&G = Posture &
Gait sub-score; Kin Fin = Kinetic Functions sub-score; f = female, m = male; Y = yes.
walking at self-selected speed over a distance of 6 m
[23], followed by three minutes of treadmill walking
at 1.0 m/s. In daily life none of the participants em-
ployed walking aids and all testing was performed
without walking aids or holding the hand rail of
the treadmill. We recorded three-dimensional kine-
matics at 100 samples/s (Vicon Nexus, Oxford Met-
rics, Oxford, UK) using a marker cluster placed at
the pelvis. During treadmill walking 3D ground
reaction forces were collected at 1000 samples/s
(custom built instrumented treadmill, Forcelink,
Culemborg, The Netherlands).
2.2 Data analysis
We calculated overground walking speed as the
mean forward velocity of the pelvis marker clus-
ter during the three overground walking trials. We
calculated gait stability for the treadmill walking
trials. Heel strike and toe-off events were extracted
from the center of pressure trajectory [24]. Gait pa-
rameters were based on 150 strides for each partic-
ipant. Step width was defined as the medio-lateral
distance between the average center of pressure
locations during subsequent single stance phases.
The coefficient of variance of stride time was calcu-
lated to assess stride time variability.
Gait stability was addressed by calculating the
short-term maximum Lyapunov exponent (λS)
from the medio-lateral displacement of pelvis
marker cluster, following Bruijn’s protocol [25]. In
short, the Euclidean distance between each data
point in state space and its nearest neighbor was
tracked over time. A divergence curve was con-
structed by taking the mean of the log of all these
time-distance curves. The short-term maximum
Lyapunov exponent is the slope of this divergence
curve over 0 − 0.5 strides. Higher values for λS
imply less gait stability [14, 25].
Additionally, we calculated the ‘margin of stabil-
ity’ between the ‘extrapolated center of mass’ and
the medio-lateral base of support [13]. To calculate
the ‘extrapolated center of mass’ we estimated the
center of mass and its velocity from the center of
pressure trajectory. The margin of stability quan-
tifies how close an inverted pendulum model of the
participant would be from falling sideways. There-
fore, a greater margin is associated to more stable
gait.
2.3 Statistical analyses
We used Student’s t-tests to compare gait param-
eters between groups. Correlations between spe-
cific gait parameters, ICARS (sub) scores and lesion
measures were evaluated within the patient group
using Pearson regression analysis. Analyses were
performed with MATLAB (The MathWorks, Inc,
Natick, MA) and a traditional level of significance
(α = 0.05) was used.
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3 Results
The cerebellar patients displayed relatively mild
functional deficits (ICARS = 6.9 ± 6.4, range
0 − 20; Table 1) and self-selected a lower over-
ground walking speed as compared to healthy con-
trols (1.12±0.12 m/s vs. 1.31±0.17 m/s; p = 0.001;
Table 2. When gait characteristics of both patients
and healthy controls were compared at an equal
speed of 1.0 m/s during treadmill walking, most
gait parameters were similar (Table 2). However,
the maximum short-term Lyapunov exponent was
higher in the patient group; hence their gait pat-
tern was less stable than that of the healthy con-
trols. Mean step width was also significantly higher
in the patient group (0.21±0.03 m) than in the con-
trol group (0.19± 0.02 m; p = 0.046).
As group differences were observed for self-
selected overground walking speed, λS , and step
width, we evaluated how these measures correlated
with clinical outcome measures as ICARS (sub)
scores and (vermal) lesion sizes. From these mea-
sures only step width was significantly correlated to
total ICARS score (r = 0.57; p = 0.014; Fig. 1). In
addition, correlation between the Posture and Gait
sub score and the Kinetic Function sub score on the
one hand and step width on the other was compa-
rable (r = 0.53 and r = 0.54, respectively). Fur-
thermore, λS appeared correlated to Posture and
Gait sub score, but this was just below significance
level (r = 0.46; p = 0.053; Fig. 1). Finally, none of
the parameters were significantly correlated to le-
sion size (|r| < 0.4; p > 0.1 for all), but within the
patients with vermal lesions (n = 11; Table 1) the
vermal lesion size was positively correlated to λS
(r = 0.64; p = 0.033; Fig. 1). This indicates that
the patients with the largest vermal lesions were the
ones with the highest λS , i.e. lowest gait stability.
In order to address relations between different
gait measures, we evaluated correlation between
self-selected overground walking speed, stride time
variability, λS , step width and margin of stabil-
ity within the patient group. Margin of stability
and step width were strongly correlated (r = 0.96;
p < 0.001; Fig. 2). In addition, stride time vari-
ability was significantly correlated to λS (r = 0.51;
p = 0.031; Fig. 2). None of the other correlations
reached significance (r = 0.44; p = 0.07 for stride
time variability vs. margin of stability; |r| < 0.4;
p > 0.1 for all others).
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Figure 1: Step width and gait stability are
correlated with clinical measures. A) Step
width was correlated to total ICARS score (Inter-
national Cooperative Ataxia Rating Scale [22]). B)
Correlation between the short-term maximum Lya-
punov exponent (λS) and the ICARS sub score for
Posture & Gait was not significant (p = 0.053).
C) Short-term maximum Lyapunov exponent (λS)
values for the patient subgroup with vermal lesions
versus the size of the lesion. Vermal lesion size was
positively correlated to λS , indicating that the pa-
tients with the largest vermal lesions were the ones
with the lowest gait stability.
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Table 2: Cerebellar patients walk with reduced dynamic stability and wider steps
Patients Healthy Controls
Mean ± sd Mean ± sd p-value
Self-selected overground walking speed [m/s] 1.12 ± 0.12 1.31 ± 0.17 0.001
Stride time [s] 1.11 ± 0.06 1.11 ± 0.05 0.91
Stance time [%] 64.72 ± 0.76 64.78 ± 0.73 0.83
Double support time [%] 15.06 ± 0.67 15.30 ± 0.67 0.31
Stride time variability [%] 2.56 ± 0.72 2.18 ± 0.67 0.14
Maximum Lyapunov exponent 1.72 ± 0.16 1.58 ± 0.14 0.011
Step width [m] 0.21 ± 0.03 0.19 ± 0.02 0.046
Margin of stability [mm] 82.6 ± 12.9 75.1 ± 10.4 0.08
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Figure 2: Several different gait parameters
were correlated. A) Margin of stability and
step width were strongly correlated. B) Short-term
maximum Lyapunov exponent (λS) was correlated
to stride time variability.
4 Discussion
In this study we aimed to gain more insights into
gait stability, gait variability and step width in
patients with focal cerebellar lesions. Based on
ICARS scores, the patients were only mildly ataxic,
and most spatio-temporal gait parameters were
similar between groups. When looking at more
sensitive gait measures however, group differences
could be observed. Gait stability was lower in the
patient group (λS was higher), and correlated to
vermal lesion size (r = 0.64; p = 0.033), indicat-
ing that the patients with the largest lesions in the
vermis were the ones with the lowest gait stability.
Such a role for vermal regions in gait stability is
in line with what was hypothesized based on ear-
lier observations of other gait measures such as step
width and stride-to-stride variations [3, 4]. We did
not apply more detailed lesion symptom mapping
because our patient sample was rather heteroge-
neous with respect to either ataxia severity (range
0− 20) or radiation and chemotherapy history.
Interestingly, while gait stability and step width
were different between these mildly ataxic patients
and healthy controls, stride time variability was
similar between groups. Hence, while on average
this patient sample did not show significant deficits
in gait variability, their gait stability was impaired.
This suggests that, in these mildly ataxic patients,
λS is a more sensitive measure of gait deficits than
gait variability.
In addition to λS , we used the margin of stabil-
ity to assess gait stability [13]. While we expected
to see a smaller margin of stability in the patient
group, the margin of stability was actually similar
between groups, with a tendency to be larger in
the patients (p = 0.08). However, patients walked
with wider steps than healthy controls. The fact
that the margin of stability depends on the base of
support and the observation that the patient group
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walked with wider steps, suggest that step widen-
ing could be used as a strategy to ensure a suf-
ficient margin of stability. This is supported by
data on amputee gait, as amputees were observed
to walk with wider steps than able-bodied controls,
with a similar margin of stability [26]. Further-
more, during walking trials with continuous bal-
ance perturbations both amputees and able-bodied
controls widen their steps in order to increase their
margin of stability [27]. Also, when walking back-
wards, healthy subjects widen their steps and in-
crease their margin of stability [28]. Along this line
of reasoning, we argue that the margin of stability
and step width should not be used as mutually inde-
pendent measures to classify gait as stable or insta-
ble, as both might or might not have been adapted
in situations or populations where balance is chal-
lenged. Evaluation of (changes/differences in) step
width is needed to interpret margin of stability val-
ues appropriately.
A next step to gain more insights into step widen-
ing as a compensation strategy could be to evaluate
how the relation between step width and the mar-
gin of stability changes in cerebellar patients and
healthy controls in conditions where normal gait is
challenged. Furthermore, only patients in a stable
recovery phase were included in the current study
(time post-op 4.8 − 30.2 yr; Table 1). Evaluating
the margin of stability in patients in an initial re-
covery phase could reveal how the nervous system
learns to compensate for specific cerebellar-related
gait deficits. In addition, alternative compensation
strategies should be evaluated in this mildly ataxic
patient population as well, since Mari et al. [29]
recently identified antagonist muscle co-activation
as a potential compensation strategy to reduce im-
balance in inherited cerebellar ataxia patients.
In summary, we observed that patients with focal
lesions in the cerebellum walked with lower gait sta-
bility and wider steps than healthy controls, while
other gait parameters were similar. Patients with
the largest vermal lesions displayed the least stable
gait pattern. These observations in mildly ataxic
patients confirm the importance of the cerebellum
(and the vermis in particular) in the supraspinal
control of gait in humans, specifically in relation to
gait stability.
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MRI data acquisition and processing 
A Philips 3T Achieva MRI scanner (Philips, Best, The Netherlands) with a 32-channel matrix head 
coil was used for image acquisition. A 3D MPRAGE high resolution T1-weighted image (repetition 
time = 970ms, echo time = 4.60ms, flip angle = 8º, 230 1-mm slices, in-plane resolution = 0.97×0.98, 
384×384 matrix) was acquired for all patients, except #18 (see Table S1). 
 
MRIcroN software (http://www.mccauslandcenter.sc.edu/mricro/mricron/index.html) was used to 
manually trace the lesions on the MPRAGE images. The SUIT toolbox 
(http://www.icn.ucl.ac.uk/motorcontrol/imaging/suit.htm [1,2]) in SPM8 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/) was used to spatially normalize the lesion traces 
to the atlas of the cerebellum [3]. In some cases (large lesions at the outer border of the cerebellum) 
spatial normalization with the SUIT toolbox was inaccurate. In those cases lesions were spatially 
normalized based on the whole brain image and the normalized lesions were manually corrected in 
atlas space when needed, based on the original image. An overlap image of the normalized lesions is 
presented in Figure S1, an overview of the lesioned lobules of each of the patients is provided in 
Table S1. 
 
 
Figure S1. Overlap of lesions normalized to the SUIT template.  
Lesion overlap is displayed on 8 axial slices as indicated in the sagital overview slice (bottom right panel). The number 
of overlapping lesions is indicated by colour code. Maximum overlap (10 patients) was around the border between the 
left paravermal lobules VIIb and Crus II (color coding according to the heat index below the cerebellar slices). 
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Table S1. Overview of lesioned lobules. 
Y = yes; L = left; R = right; B = both; FN = fastigial nuclei; IN = interposed nuclei; DN = dentate nuclei  
 
 
 
